E-cigarette vs. Nicotine Inhaler Comparisons

Rutgers The State University of New Jersey

Status: Completed

Conditions: Smoking

Treatments: Other: Electronic Cigarette; Other: Nicotrol Inhaler

Study type: Interventional

Funder types: Other

Identifiers

NCT02294617

P30CA072720 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The goal of this study is to get information from current smokers about how they feel towards both the electronic cigarette (e-cigarette) and the nicotine oral inhaler. This will include beliefs, harms, appeal, ease of use, enjoyment, and their use for helping people stop smoking.

Full description

Subjects will be seen at Baseline, then 3-days post-baseline, then 9 days post-baseline for post product use questionnaires and carbon monoxide monitoring. The time frame for follow up is 6 months post Baseline visit.

Enrollment: 41 patients

Sex: Male

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Subjects will be smokers 18 years or older, who have had no previous experience with either the e-cigarette or the nicotine oral inhaler, and will be recruited from the local community. They can currently smoke any amount or frequency and with any level of motivation to stop smoking.

Exclusion criteria

• Exclusion criteria include recent (within 2 weeks) myocardial infarction or angina, poorly controlled asthma/chronic obstructive pulmonary disease , active substance abuse, pregnancy, or current use of any other cessation medications

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

41 participants in 2 patient groups

Nicotrol Inhaler

Active Comparator group

Description:

Subjects will use the Nicotine Inhaler for 3 days.

Treatment:

Other: Nicotrol Inhaler

Electronic Cigarette

Active Comparator group

Description:

Subject will use the electronic cigarette for 3 days.

Treatment:

Other: Electronic Cigarette